Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study
Title:
Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study
Author:
Chari, Ajai Touzeau, Cyrille Schinke, Carolina Minnema, Monique C Berdeja, Jesus G Oriol, Albert van de Donk, Niels W C J Rodríguez-Otero, Paula Morillo, Daniel Martinez-Chamorro, Carmen Mateos, María-Victoria Costa, Luciano J Caers, Jo Rasche, Leo Krishnan, Amrita Ye, Jing Christine Karlin, Lionel Lipe, Brea Vishwamitra, Deeksha Skerget, Sheri Verona, Raluca Ma, Xuewen Qin, Xiang Ludlage, Hein Campagna, Michela Masterson, Tara Hilder, Brandi Tolbert, Jaszianne Renaud, Thomas Goldberg, Jenna D Kane, Colleen Heuck, Christoph San-Miguel, Jesus Moreau, Philippe
Appeared in:
The Lancet. Haematology
Paging:
Volume 12 () nr. 4 pages e269-e281
Year:
2025
Contents:
Publisher:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license